Rigel Pharmaceuticals (RIGL) Tops Q1 EPS by 44c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $47.28 --0%
Revenue Growth %: +15.2%
Financial Fact:
General and administrative: 4.56M
Today's EPS Names:
ANAB, ANIX, MNY, More
Revenue Growth %: +15.2%
Financial Fact:
General and administrative: 4.56M
Today's EPS Names:
ANAB, ANIX, MNY, More
Join SI Premium – FREE
Rigel Pharmaceuticals (NASDAQ: RIGL) reported Q1 EPS of $0.44. Revenue for the quarter came in at $58.8 million.
For earnings history and earnings-related data on Rigel Pharmaceuticals (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KeyBanc Starts PPG Industries (PPG) at Overweight
- Jefferies conference highlights mining sector optimism on copper
- KeyBanc Starts Dow Inc. (DOW) at Sector Weight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
